ORLANDO, PIERFRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 269
EU - Europa 192
AS - Asia 65
Totale 526
Nazione #
US - Stati Uniti d'America 268
GB - Regno Unito 72
IT - Italia 52
CN - Cina 35
UA - Ucraina 25
SE - Svezia 19
VN - Vietnam 12
DE - Germania 9
FI - Finlandia 8
TR - Turchia 8
SG - Singapore 6
IE - Irlanda 5
IN - India 2
BD - Bangladesh 1
CA - Canada 1
FR - Francia 1
KR - Corea 1
PL - Polonia 1
Totale 526
Città #
Southend 69
Woodbridge 52
Ann Arbor 37
Fairfield 37
Jacksonville 21
Cambridge 17
Ashburn 16
Chandler 13
Seattle 13
Wilmington 13
Dong Ket 12
Houston 11
Nanjing 10
Beijing 7
Urbino 7
Izmir 6
Boardman 5
Cento 5
Dublin 5
Singapore 5
Helsinki 4
Melito Di Napoli 4
Changsha 3
Nanchang 3
Princeton 3
Ascoli Piceno 2
Berlin 2
Bremen 2
Düsseldorf 2
Forlì 2
Fossombrone 2
Istanbul 2
Jinan 2
New York 2
Niardo 2
Ningbo 2
Senigallia 2
Shenyang 2
Ancona 1
Augusta 1
Avellino 1
Castellarano 1
Chiswick 1
Dhaka 1
Fano 1
Grafing 1
Hangzhou 1
Hebei 1
Indiana 1
Jiaxing 1
Kunming 1
London 1
Meda 1
Montalto delle Marche 1
Montesilvano 1
San Diego 1
San Francisco 1
San Mateo 1
Santa Clara 1
Seongnam 1
Shanghai 1
Tianjin 1
Toronto 1
Viterbo 1
Totale 430
Nome #
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 220
Combination of Coenzyme Q10 Intake and Moderate Physical Activity Counteracts Mitochondrial Dysfunctions in a SAMP8 Mouse Model 166
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 156
Totale 542
Categoria #
all - tutte 1.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 33 4 10 10 7 5 7 4 5
2020/202182 7 5 1 10 2 4 0 4 16 10 9 14
2021/202240 2 5 4 8 0 1 3 2 2 2 3 8
2022/202348 5 4 2 10 4 9 0 2 8 1 2 1
2023/202416 1 4 1 4 1 2 0 0 0 2 0 1
2024/202516 4 1 11 0 0 0 0 0 0 0 0 0
Totale 542